加州和华盛顿州卫生官员在今年春季面对麻疹疫情时，于5月向美国疾病控制与预防中心提出请求，希望验证一项可在8小时内完成500例病例诊断的新型麻疹检测方法 1。然而CDC在两个月后才做出回应，称其他工作优先级更高，无法抽出时间推进该项目 1。
西部海岸卫生联盟随后向新任CDC主任埃里卡·施瓦茨提出敦促，要求该机构开发并推广高通量检测协议 1。州卫生官员指出，诊断检测的可用性和处理速度在传染病爆发初期对于疾病控制至关重要 1。该联盟包括加州、华盛顿州、俄勒冈州和夏威夷州等成员 1。
California and Washington state health officials requested that the Centers for Disease Control and Prevention validate a new measles diagnostic test in May 2024, as both states faced measles outbreaks 1. The test offered significant potential, capable of diagnosing up to 500 cases within eight hours 1. However, the CDC did not respond for approximately two months, ultimately stating that other priorities prevented the agency from committing resources to the validation effort 1.
The delayed response prompted regional health authorities to escalate their concerns. The Western States Health Alliance, comprising California, Washington, Oregon, and Hawaii, sent a letter to the newly appointed CDC Director Erica Schwartz, who assumed office in August, urging the agency to develop and distribute high-throughput testing protocols for measles 1. Health officials emphasized that the availability and speed of diagnostic tests could substantially mitigate the impact of infectious disease outbreaks during their early stages 1.
评论
还没有评论，欢迎留下第一条。